Easton Pharmaceuticals (Easton Pharmaceuticals) Dividends per Share : $0.00 (TTM As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Dividends per Share?

Easton Pharmaceuticals's dividends per share for the three months ended in Sep. 2021 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2021 was 0.00. As of today, Easton Pharmaceuticals's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Easton Pharmaceuticals Dividends per Share Historical Data

The historical data trend for Easton Pharmaceuticals's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Dividends per Share Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Dividends per Share

Get a 7-Day Free Trial

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Easton Pharmaceuticals's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Easton Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Easton Pharmaceuticals's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Easton Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Easton Pharmaceuticals's Dividend Yield % falls into.

Easton Pharmaceuticals Dividends per Share Calculation

Dividends paid to per common share.

Easton Pharmaceuticals (OTCPK:EAPH) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Easton Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Sep. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2021 )	/	EPS without NRI (Q: Sep. 2021 )
	=	0	/	-0
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Easton Pharmaceuticals Dividends per Share Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.